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Introduction
The retinoblastoma susceptibility protein (Rb) family, including 
pRb, p107, p130, and their associated proteins, have been impli-
cated  in  adipogenesis  and  regulation  of  energy  metabolism 
(Hallenborg et al., 2009). Recently, we found that mice lacking 
p107 displayed an extensive replacement of white adipose tissue 
(WAT) with brown adipose tissue (BAT; Scimè et al., 2005). The 
p107-deficient WAT depots contain brown-type adipocytes, ex-
press peroxisome proliferator–activated receptor gamma co- 
activator-1 (PGC-1) and uncoupling protein 1 (UCP-1), and 
appear poorly differentiated. Deficiencies in adipose tissue, or lipo-
dystrophy, are normally associated with a metabolic syndrome 
that resembles obesity due to an inability to process fat in the diet 
(Reue and Phan, 2006). Paradoxically, p107
/ mice exhibit a 
lean metabolic phenotype in spite of an apparent lipodystrophy 
(Scimè et al., 2005).
When high levels of lipid cannot be stored in WAT, it is 
predominately partitioned into skeletal muscle, which can lead 
to metabolic consequences of impaired insulin responsiveness 
(insulin resistance) and type II diabetes mellitus (Lelliott and 
Vidal-Puig, 2004; Kelley, 2005). In humans and animals, in-
creased capacity for lipid oxidation by muscle is correlated to 
increased insulin sensitivity, reduced adipocyte size, leanness, 
and aerobic fitness (Luquet et al., 2003; Ryder et al., 2003;   
Ukropcova et al., 2005).
Skeletal muscle fiber types are generally classified ac-
cording to four major myosin heavy chain (MyHC) isoforms 
that display differences with respect to their metabolic poten-
tial (Pette and Staron, 2001). They consist of slow contracting 
type I oxidative, fast contracting type IIa oxidative, and fast 
contracting glycolytic type IIx and IIb fibers. Type I and IIa 
M
ice lacking p107 exhibit a white adipose de-
ficiency  yet  do  not  manifest  the  metabolic 
changes typical for lipodystrophy, and instead 
exhibit low levels of serum triglycerides and a normal liver 
phenotype. When fed a high fat diet, p107-null mice still 
did not accumulate fat in the liver, and display markedly 
elevated energy expenditures together with an increased 
energy preference for lipids. Skeletal muscle was therefore 
examined, as this is normally the major tissue involved 
in whole body lipid metabolism. Notably, p107-deficient 
muscle express increased levels of peroxisome proliferator–
activated receptor gamma co-activator-1 (PGC-1) and 
contained increased numbers of the pro-oxidative type I 
and type IIa myofibers. Chromatin immunoprecipitation 
revealed  binding  of  p107  and  E2F4  to  the  PGC-1 
proximal promoter, and this binding repressed promoter 
activity in transient transcription assays. Ectopic expres-
sion of p107 in muscle tissue in vivo results in a pro-
nounced  20%  decrease  in  the  numbers  of  oxidative   
type IIa myofibers. Lastly, isolated p107-deficient muscle 
tissue display a threefold increase in lipid metabolism. 
Therefore, p107 determines the oxidative state of multiple 
tissues involved in whole body fat metabolism, including 
skeletal muscle.
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Results
Mice lacking p107 exhibit a life-long white 
adipose deficiency
White adipocyte differentiation is deficient in p107
/ BALB/c 
mice, resulting in a lean phenotype exemplified by a significant 
reduction in total adiposity (Scimè et al., 2005). We assessed 
whether the reduced adiposity remained throughout the lifetime 
of the mutant animals. Both male and female p107
/ mice re-
mained leaner than their wild-type siblings, weighing as much 
as 30% less after 1 yr of age (P < 0.0003; Fig. 1 A). As the fat con-
tent is the main contributor to the leanness in young mice, we 
determined if lipids had accumulated in adipose tissue of aged 
p107
/ mice.
The adipocyte paucity was evident, as shown by the reduced 
lipid levels within WAT and BAT in older aged mice (Fig. 1,   
B and C). At 1 yr of age, p107
/ WAT is characterized as non-
uniform smaller sized adipocytes appearing much the same as in   
8 wk of age (Fig. 1 B). By comparison, adipocytes within the WAT 
of 1-yr-old wild-type mice increased in area by as much as 42.8%   
(Fig. 1 C). BAT for older p107-deficient mice retained small sized 
multilocular adipocytes as compared with wild-type mice aged   
1 yr that had become engulfed by lipids and infiltrated with 
unilocular-appearing cells (Fig. 1 D). In addition, 2-yr-old p107
/ 
mice did not exhibit any significant weight gain and were simi-
lar in weight to 3-mo-old mutant mice. Collectively, these results 
suggest that the p107
/ lean phenotype is retained throughout 
the lifetime of the animal.
Mice lacking p107 are resistant to  
weight gain
Male mice were challenged with an HF diet, which normally in-
duces obesity, containing 60% (wt/wt) fat. Wild-type mice fed 
an HF diet for 60 d exhibited an obvious weight gain relative to 
the maintenance of leanness in the p107
/ animals (Fig. 2 A). 
This was further illustrated by the testicular fat pads from repre-
sentative animals on the HF diet that revealed extremely blunted 
weight gain by the p107
/ mice (Fig. 2 B).
The HF diet resulted in considerable lipid accumulation 
and hypertrophy in both brown and white adipocytes of wild-
type animals relative to p107
/ mice (Fig. 2 C). As expected, 
hematoxylin and eosin (H&E) staining of liver tissue sections 
also revealed that the wild-type mice were unable to fully ac-
commodate the increased fat load in their diet. The wild-type 
mice developed fatty liver as demonstrated by the presence of 
lipids within their hepatocytes (Fig. 2 C). Strikingly, the livers 
of p107
/ mice did not appreciably manifest any liver anoma-
lies despite ingesting the same diet, and displayed an overall 
normal appearance.
The total weight and adiposity of the control and experi-
mental animals were also evaluated before and after feeding on 
the HF diet for 60 d. The p107-deficient mice failed to gain any 
weight, whereas littermate controls significantly (P < 0.02) gained 
as much as 27% more weight after completion of the HF diet 
(Fig. 2 D, compare day 0 versus day 60). Moreover, the body 
weight for p107
/ mice compared with controls before and after 
the HF diet was significantly lower (P < 0.03 and P < 0.002,   
muscle fibers are highly oxidative, containing many mitochon-
dria that provide the muscle with the production of a large sup-
ply of energy in the form of ATP. Type IIx and IIb fibers rely 
for the most part on glycolytic metabolism as a major energy 
source, have few mitochondria, exert quick contractions, and 
fatigue easily.
Many studies have demonstrated that obesity and type II 
diabetes are associated with a lower percentage of oxidative type I 
fibers and a higher percentage of glycolytic type II fibers (Hickey 
et al., 1995; Nyholm et al., 1997; Tanner et al., 2002). Moreover, 
type I fibers are more insulin sensitive compared with type IIb   
fibers (Lillioja et al., 1987; Hickey et al., 1995).
The major site for oxidative metabolism is skeletal muscle, 
with as much as 90% of the energy needs during rest derived 
from fatty acids (Dagenais et al., 1976). A leading abnormal-
ity in obesity is a reduction in the capacity of muscle for lipid 
oxidation as measured in the whole body, or from muscle homog-
enates or strips (Kelley et al., 1999; Kim et al., 2000; Hulver   
et al., 2003; Thyfault et al., 2004). The fatty acid oxidation im-
pairment is also apparent within primary muscle cells of ex-
tremely obese individuals (Hulver et al., 2005; Ukropcova et al., 
2005). In addition, the reduced capacity in lipid oxidation is cor-
related with a propensity toward weight gain and obesity (Zurlo 
et al., 1990; Marra et al., 2004).
In response to physiological pressures such as exercise 
and diet, skeletal muscle can remodel to switch fiber types 
by activating signaling pathways that inevitably control gene 
expression patterns in progenitor cells and/or muscle fibers 
(Bassel-Duby and Olson, 2006). Recently, the transcriptional 
coactivator PGC-1 has been implicated to play an impor-
tant pro-oxidative role in muscle (Puigserver et al., 1998; Wu 
et al., 1999). PGC-1 has been shown to regulate a myriad of 
metabolic activities including enhancing mitochondrial func-
tion  and  biogenesis  in  skeletal  muscle.  Fiber-type  enrich-
ment of pro-oxidative type I and type IIa fibers is observed 
when PGC-1 is expressed at physiological levels in trans-
genic  mice  under  a  muscle  specific  promoter  (Lin  et  al., 
2002, 2005).
The lean metabolic phenotype of p107
/ mice suggested 
the hypothesis that the mice may have an elevation in lipid   
metabolism in a tissue such as skeletal muscle. Nuclear p107 
expression has been well documented in differentiated myo-
tubes and muscle tissue by immunostaining (Baldi et al., 1997; 
Parakati and DiMario, 2005), which supports a role for p107 in 
noncycling myofibers. In this study, we find that p107 plays a 
central role in determining the fiber type character of skeletal 
muscle. Our findings demonstrate that the p107-ablated ani-
mals have higher levels of oxidative MyHC type I and type IIa 
fibers. This plays a role in the increased efficiency of fatty acid 
metabolism in p107
/ mice when fed a high fat (HF) diet.   
Indeed, p107 influences the oxidative nature of skeletal muscle 
by directly repressing PGC-1 expression in myogenic cells. 
These results indicate a central role for p107 in the control of 
whole body fat metabolism. Therefore, our data suggest p107 
as a therapeutic target for the treatment of various metabolic 
and neuromuscular disorders by influencing the oxidative state 
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diet by measuring their respiratory exchange ratios (RERs).   
A lower RER is an indication of a greater fat metabolism, whereas 
a higher RER is associated with a greater carbohydrate metabo-
lism. On the normal diet, the RER values for both p107
/ and 
control mice were not significantly different and reflected the   
nature of this diet (Fig. 3 B). As expected on the HF diet, because 
lipids are the predominate source of energy, both p107
/ and 
wild-type mice had lower RER values than when feeding on the 
regular diet (Fig. 3 B). However, the p107
/ mice had a signifi-
cantly lower RER after 1 and 2 mo on the diet (P < 0.05 and   
P < 0.03, respectively).
The major site for whole body oxidative metabolism is 
skeletal muscle, with as much as 90% of the energy needs during 
rest derived from fatty acids (Dagenais et al., 1976). Therefore, 
we next asked whether the high-lipid metabolism phenotype of 
p107
/ mice can be attributed to skeletal muscle. Lipid metabo-
lism in muscle was assessed by measuring the oxidative poten-
tial of isolated gastrocnemius using radiolabeled palmitic acid 
(Fig. 3 C). Indeed, we found a significant threefold increase in 
-oxidative potential in p107
/ muscle. This marked increase 
strongly supports the assertion that the increased capacity in   
-oxidative potential in muscle has a significant role in contrib-
uting to the lean phenotype of p107 mutant mice.
Muscle in p107
/ mice exhibits enhanced 
pro-oxidative capacity
To investigate the basis for the enhanced ability of p107- 
deficient muscle to metabolize lipids, we analyzed the expression 
respectively). To test if the weight gain differences observed were 
caused by fat mass expansion, we assessed the percentage adi-
posity of the animals (Fig. 2 E). The total percentage of fat in the 
wild-type animals is at least three times greater after completion 
of the fat-laden diet as compared with the p107
/ animals   
(Fig. 2 E). This is corroborated by significantly higher weight in 
individual fat depots in control mice (Fig. 2 F). Contrarily, the 
size of the BAT depots between the animals remained relatively 
similar. Collectively, these results indicate that p107
/ mice re-
main remarkably lean when challenged with an HF diet.
Mice lacking p107 are more efficient at  
 oxidation
Typically,  lipodystrophic  mice  exhibit  elevated  triglycerides   
and free fatty acids in the serum as well as fatty liver changes, and 
they do not show an elevation in energy expenditures (Reue and 
Phan, 2006). However, p107
/ mice do not exhibit these 
changes despite the increased lipid load (Figs. 2 and S1). Nota-
bly, p107
/ mice fed a regular diet have significantly higher 
metabolic rates than their littermate controls (Scimè et al., 2005). 
Therefore, we tested if this characteristic was responsible for 
maintaining the p107 mutant phenotype when challenged with 
an HF diet.
After 60 d on the HF diet, the mutant mice exhibited signifi-
cantly higher metabolic rates than their wild-type controls. This 
suggests that the maintenance of a higher metabolic rate leads to 
an increase in fatty acid metabolism (Fig. 3 A). We therefore 
evaluated the fuel preference of the mice before and after the HF 
Figure  1.  Aged p107
/ mice display underdevel-
oped WAT depots. (A) Graphical representation of the 
weight of 1-yr-old wild-type and p107
/ mice (n = 5   
for  p107
+/+  and  n  =  4  for  p107
/).  The  asterisk 
denotes significance (P < 0.0003). (B) H&E staining 
of inguinal WAT for wild-type and p107
/ mice at   
8 wk and 1 yr of age. (C) Graphical representation of 
the mean cross-sectional area (CSA) of white adipo-
cytes for wild-type and p107
/ mice at 8 wk (w) and   
1  yr  (yr)  of  age.  The  asterisk  denotes  significance   
(P < 0.009). (D) H&E staining of interscapular BAT for 
wild-type and p107
/ mice at 8 wk and 1 yr of age. 
Note the increased lipid deposition in the wild-type 
animals after 1 yr. Error bars indicate SD.JCB • VOLUME 190 • NUMBER 4 • 2010   654
metabolism, did not display significant changes in expression 
levels (Fig. 4 A). Lastly, UCP-2 and UCP-3 were significantly 
up-regulated in the p107
/ muscle relative to wild-type controls 
(Fig. 4 A). Collectively, these results indicate that the molecular 
components involved in fatty acid metabolism and  oxidation 
are markedly increased in p107
/ skeletal muscle.
Type I and IIa muscle fibers are highly oxidative, contain-
ing many mitochondria that provide the muscle with the produc-
tion of a large supply of energy in the form of ATP. Therefore, we 
examined the distribution of fiber types in p107-deficient muscle. 
levels of various genes involved in regulating energy metabo-
lism in the tibialis anterior (TA) muscle when fed a normal diet.   
In adult mice, we first examined the expression of fatty acid 
binding protein 3 (FABP3), which is involved in the intramyo-
cellular transport of free fatty acid, and carnitine palmitoyltrans-
ferase Ib (CPT1b), which is involved in the uptake of fatty acid 
from the cytoplasm into the mitochondrial matrix. Strikingly, we 
observed a 3.6-fold increase in FABP3 and a 2.1-fold increase 
in CPT1b levels by quantitative RT-PCR (qRT-PCR; Fig. 4 A).   
In contrast, Glut4 and Glut5, which are involved in carbohydrate 
Figure 2.  p107
/ mice are refractory to fat accumulation after HF feeding. (A) Representative dorsal view of wild-type and p107
/ mice after 60 d on 
an HF diet. Note the lack of WAT pads for the p107
/ mouse. (B) Representative gross comparison of testicular fat depots between adult wild-type and 
p107
/ mice after 60 d on HF diet. (C) H&E staining of inguinal WAT, interscapular BAT, and livers for representative wild-type and p107
/ mice after 
60 d on an HF diet. Note the accumulation of lipids within cells of the various tissues for the wild-type mouse but not the p10
/ mouse. (D) Graphical rep-
resentation of body weight for wild-type and p107
/ mice before (day 0) and after an HF diet for 60 d (day 60; n = 5 and 4 for p107
+/+ and p107
/, 
respectively). Asterisks indicate significance between wild-type and p107
/ at day 0 (P < 0.03) and day 60 (P < 0.002) and between day 0 and day 
60 for wild-type mice (P < 0.02, n = 5 and 4 for p107
+/+ and p107
/, respectively). (E) Percent adiposity for wild-type and p107
/ mice after 60 d of 
being fed an HF diet (day 60; n = 5 and 4 for p107
+/+ and p107
/, respectively). Asterisks denote significance (P < 0.000006; n = 3). (F) Weights of 
various fat depots between p107
/ and wild-type male mice after an HF diet for 60 d. Asterisks denote significance for inguinal (P < 0.002), testicular   
(P < 0.0005), and peritoneal (P < 0.001; n = 3) samples. Note that p107
/ mice do not gain any appreciable weight at the level of lipid accumulation 
in WAT after HF feeding. Error bars indicate SD.655 Muscle fiber type determination by p107 • Scimè et al.
wild-type littermate controls (Fig. 4 D). The increase in type I   
fibers was also evident in the mixed glycolytic and oxidative   
fiber type gastrocnemius muscle (unpublished data).
We next assessed the percentage of type IIa pro-oxidative 
fibers within various muscle groups to find if they influence the 
oxidative nature of p107
/ muscle. We found significantly in-
creased percentages of type IIa fibers within the TA (P < 0.02) 
and pectoralis (P < 0.05) muscles, and higher overall levels 
within the diaphragm muscles of p107
/ mice (Fig. 4 E). 
p107
/ TAs and pectoralis muscles had a mean increase of 
82.4% and 31.1% in the numbers of type IIa fibers, respectively, 
as  compared  with  wild-type  littermate  controls.  Notably,  the   
total number of fibers in the p107
/ TA was similar to wild-type 
TA, which suggests that the number of IIb fibers must be corre-
spondingly decreased.
We also tested if the observed muscle fiber type phenotype 
in the p107
/ mice was caused by a myoblast cell autonomous 
affect. This was accomplished by knocking down p107 expres-
sion by transient transfection of siRNA specific for p107 in three 
different primary myoblast isolates before their differentiation 
into myotubes (Fig. 4 F). By Western blot analysis, siRNA- 
mediated inhibition of p107 protein expression revealed increased 
oxidative type IIa (MyHC IIa) fiber content and a correspond-
ing decrease in type IIb fibers (MyHC IIb) after differentiation   
(Fig. 4 F). Quantification of the data demonstrated that the levels 
of MyHC IIa significantly (P < 0.01) increased twofold, and 
that MyHC IIb significantly decreased (P < 0.05) by as much as   
75% when compared with the nonsilencing control siRNA 
(CTL-siRNA; Fig. 4 G).
Our experiments thus document that p107
/ muscle con-
tains greatly increased numbers of pro-oxidative type fibers that 
result from a cell-autonomous deficit in p107 during myogenic 
precursor differentiation. Together, these data suggest that the 
increased pro-oxidative nature of skeletal muscles in p107
/ 
mice is responsible for the overall increased lipid utilization.
PGC-1 transcription is negatively 
regulated by p107
Recent work has implicated PGC-1 in muscle fiber type deter-
mination and switching. For example, muscle-specific expres-
sion of PGC-1 in transgenic mice induces activation of genes 
typical of oxidative fibers (Lin et al., 2002). Our recent study 
demonstrated that p107 negatively regulates PGC-1 and thus 
UCP-1 in white adipose tissue (Scimè et al., 2005), which sug-
gests the hypothesis that p107 similarly regulates PGC-1 in 
muscle. Therefore, we evaluated the levels of PGC-1 in the TA 
muscle by qRT-PCR.
Importantly, PGC-1 mRNA levels in p107
/ TA mus-
cle were significantly (P < 0.004) higher by almost threefold 
as compared with wild-type littermate controls (Fig. 5 A).   
We next confirmed if the higher levels of PGC-1 in p107
/ 
mice were specific to myogenic cells within the tissue. This was 
accomplished by isolating primary myoblasts from wild-type 
and mutant mice and inducing myogenic differentiation. Levels 
of PGC-1 mRNA were significantly (P < 0.008) elevated by 
about twofold in differentiated p107
/ myotubes (Fig. 5 A). 
Indeed, p107 and PGC-1 displayed an inverse correlation in 
We first assessed the mitochondrial oxidative enzyme activity   
in  the  TA  by  staining  with  nitro-blue  tetrazolium  (NBT),   
a  histochemical  stain  against  the  pro-oxidative  component 
NADH-reductase (Fig. 4 B). Oxidative muscle fibers are darkly 
stained in NBT, whereas intermediately oxidative and nonoxida-
tive fibers are stained lighter. Representative tissue sections of 
NBT staining demonstrated that the p107
/ mice had a dramati-
cally higher content of darkly and intermediate staining fibers 
within their TAs, compared with the littermate control (Fig. 4 B). 
Collectively, these data suggested that p107-deficient fibers are 
much more oxidative.
To investigate whether the increased oxidative capacity 
was due to increased numbers of pro-oxidative type I and/or   
type IIa fibers, we immuno-stained cross sections of the TA from 
p107
/ and wild-type mice for slow type I MyHC fibers (Fig. 4 C). 
Type I immunostaining revealed that p107
/ TA displayed   
a fourfold (P < 0.02) increase in type I fibers relative to their 
Figure 3.  Elevated metabolic rate in p107
/ mice induced by an HF diet. 
(A) Mean 24 h mass-adjusted total energy expenditure for wild-type and 
p107
/ mice after 1 mo and 2 mo of HF feeding (n = 4 for both p107
+/+ 
and p107
/). (B) RER for wild-type and p107
/ mice on a chow diet 
or at the end of 1 and 2 mo of an HF diet (n = 4 and 5 for p107
/ and 
p107
+/+, respectively). Asterisks denote significance P < 0.05 for 1 mo 
and P < 0.03 at 2 mo (n = 4 for both p107
+/+ and p107
/). (C) Exog-
enous palmitate oxidation per gram per minute of gastrocnemius muscle   
ex vivo over time (n = 12 and 8 for p107
/ and p107
+/+, respectively). 
The asterisk denotes significance (P < 0.02). Error bars indicate SD.JCB • VOLUME 190 • NUMBER 4 • 2010   656
Figure 4.  Elevated oxidative function of p107
/ skeletal muscle. (A) Graphical representation of the relative fold change expression between wild-type 
and p107
/ mice for FABP3, CPT1b, Glut4, Glut5, UCP-2, and UCP-3 in TA muscle using qRT-PCR. Asterisks denote significance (P < 0.05, P < 0.004,   
P < 0.005, and P < 0.005 for FABP3, CPT1b, UCP-2, and UCP-3, respectively). n = 4 for both p107
+/+ and p107
/. (B) Representative NADH reductase 
staining with NBT (NADH-TR) of TA fibers for wild-type and p107
/ mice. Note the obvious abundance of darkly stained pro-oxidative fibers for the 
p107
/ TA. (C) Type I MyHC (red), Laminin (green), and DAPI (blue) fluorescence immunostaining of representative TA sections for wild-type and p107
/ 
mice. Note the increased levels of oxidative fibers for the p107
/ muscle in the mainly mixed type II muscle. (D) Graphical representation of the number 
of type I fibers per TA for wild-type and p107
/ mice. The asterisk denotes significance (P < 0.02; n = 3 for both p107
+/+ and p107
/). (E) Graphical 657 Muscle fiber type determination by p107 • Scimè et al.
Ectopic expression of p107 influences fiber 
type determination
Our experimental results suggested the hypothesis that p107 
negatively regulates PGC-1 transcription in skeletal muscle to 
the level of expression during growth and differentiation, which 
supports the assertion that p107 negatively regulates PGC-1 
transcription  (Fig.  5  B).  Isolated  primary  myoblasts  lacking 
p107 in growth media also exhibited an 2.5-fold increase in 
PGC-1 mRNA (Fig. 5 C). Collectively, these results strongly 
support the conclusion that the pro-oxidative nature of p107
/ 
skeletal muscle is a consequence of a cell-autonomous loss of 
p107 and subsequent up-regulation of PGC-1 transcription.
Examination of the sequence of the PGC-1 proximal 
promoter revealed multiple potential p107/E2F binding sites. 
Therefore, we tested whether p107 binds to the PGC-1 proxi-
mal promoter by quantitative chromatin immunoprecipitation 
(ChIP). Assays were performed using primers that amplified a 
311-bp fragment located 134 to 445 bp upstream of the 
PGC-1 transcriptional start site (Fig. 6 A). ChIP analysis re-
vealed robust binding of p107 in proliferating myoblasts and 
differentiated myotubes. In contrast, neither Rb nor p130 ex-
hibited notable binding under growth or differentiation condi-
tions (Fig. 6 A).
Rb family factors such as p107 are recruited to promoters 
to repress transcription through binding to DNA-binding tran-
scription factors such as E2F1 and E2F4 (Mulligan and Jacks, 
1998). Therefore, we used ChIP to test whether E2F1 and E2F4 
bind the PGC-1 proximal promoter (Fig. 6 B). Notably, quan-
titative ChIP assays revealed that E2F4 bound the PGC-1 pro-
moter in proliferating myoblasts and differentiated myotubes, 
whereas E2F1 interacted to a lesser degree only after differen-
tiation. Therefore, these results are consistent with the notion 
that p107 controls PGC-1 activity at the transcriptional level 
through binding of E2F-4 and E2F1 in sites located in the proxi-
mal promoter.
To investigate the ability of p107 to negatively regulate 
PGC-1 transcription, we used transient transcription assays 
using a luciferase reporter under the control of the PGC-1  
3.1-kb proximal promoter. Overexpression of p107 signifi-
cantly repressed the activity of the PGC-1 proximal promoter 
at 48 h after differentiation (Fig. 6 C). Expression of p107A4a, 
a nonphosphorylatable form of p107 (K657-L660 replaced by 
alanine), significantly repressed PGC-1 promoter activity in 
growth media. Notably, p107A4 cannot be phosphorylated by 
Cdk2 (Leng et al., 2002). Therefore, these data suggest that p107   
regulates the PGC-1 transcription in a Cdk2 phosphorylation–
dependent manner (Fig. 6, C and D). Thus, overexpression   
of p107 in growth displayed a modest repression effect on   
PGC-1 transcription likely caused by the high level of Cdk2 
activity (Fig. 6 D).
Collectively, these results demonstrate that p107 controls 
PGC-1 activity at the transcriptional level, dependent on the 
phosphorylation status of p107 and binding to E2F4 at a site 
likely located within the proximal promoter.
representation of the number of type IIa fibers per diaphragm (DM), pectoralis (PEC), and TA for wild-type and p107
/ mice. Note that the different 
muscle groups have pro-oxidative fibers. The asterisks denote significance (P < 0.05 and P < 0.02 for PEC and TA, respectively; n = 3 for both p107
+/+ 
and p107
/). (F) Immunoblot triplicates of p107-siRNA knockdown myotubes using antibodies directed against the indicated proteins. A nonsilencing 
siRNA (CTL-siRNA) was used as a control, and equal protein loading was confirmed by blotting for total MyHC. MyHCIIa, MyHC type IIa; MyHCIIb,   
MyHC type IIb. (G) Background-corrected gray values from F were normalized to the total MyHC levels, and the CTL-siRNA was set to 100%. Compiled 
data are expressed as mean ± SEM, with the level of significance indicated as: **, P < 0.01; * P < 0.05. Error bars indicate SD.
 
Figure  5.  Elevated  PGC-1  expression  in  p107
/  skeletal  muscle.  
(A) Graphical representation of the relative fold change expression for 
PGC-1 in wild-type and p107
/ TA muscle (Tissue) and differentiated pri-
mary myoblasts (Myotubes) using qRT-PCR. Asterisks denote significance 
(P < 0.004 and P < 0.008 for tissue and myotubes, respectively; n = 3 
for both p107
+/+ and p107
/). (B) Graphical representation of the rela-
tive expression, using qRT-PCR for PGC-1 and p107 in a time course of 
differentiation, for primary myoblasts. GM, growth media; 1DM, 2DM, 
and 3DM, 1, 2 and 3 d in differentiation media, respectively. Note the 
reciprocal expression pattern for p107 and PGC-1 through differentiation 
(n = 3). (C) Graphical representation of the relative fold change expression 
for PGC-1 in wild-type and p107
/ myoblasts in growth using qRT-PCR. 
Asterisks denote significance (P < 0.004; n = 3 for both p107
+/+ and 
p107
/). Error bars indicate SD.JCB • VOLUME 190 • NUMBER 4 • 2010   658
Our results revealed that when the cmv-p107 plasmid was 
electroporated into muscle, the number of oxidative type IIa   
fibers was significantly reduced relative to TA muscles elec-
troporated with empty vector (sham; Fig. 7 D). Therefore, ec-
topic overexpression of p107 within skeletal muscle fibers 
directly promotes a less oxidative myofiber character in a cell-
autonomous manner.
Discussion
Our experiments support a role for p107 in controlling fiber 
type specification at the level of the coactivator PGC-1. The 
pro-oxidative fiber type composition corresponds to significant 
increases in the expression of PGC-1, a key regulator of   
modulate the oxidative state. To directly test this hypothesis, we 
ectopically expressed p107 in skeletal muscle to ask whether 
p107 overexpression was sufficient to influence the fiber type 
character in vivo.
Cytomegalovirus (CMV) expression plasmids were elec-
troporated directly into the TA muscle using conditions that 
result in high-level expression in 80% of the fibers (Le Grand 
et al., 2009). The expression of Flag-tagged p107 was read-
ily visible at 10 d and 30 d after electroporation by Western   
blotting and PCR analysis (Fig. 7, A and B). 21 d after trans-
fer, the TA muscles from electroporated and nonelectropor-
ated contralateral legs from each mouse were isolated, and the 
percentage of muscle fibers expressing type IIa MyHC was 
enumerated (Fig. 7 C).
Figure  6.  PGC-1  transcription  is  negatively  regu-
lated by p107/E2F binding. (A) Quantitative ChIP as-
says for control immunoglobulin (IgG), p107, Rb, and 
p130 to the PGC-1 promoter on a fragment 134 to 
445 bp upstream of the transcription start in growth 
(Growth)  and  48  h  after  differentiation  (Differentia-
tion). Results are given as fold enrichment relative to 
IgG (n = 3). (B) Quantitative ChIP assays for control 
immunoglobulin (IgG), E2F1, and E2F4 to the PGC-1 
promoter on a fragment 134 to 445 bp upstream 
of the transcription start in growth (Growth) and 48 h 
after differentiation (Differentiation). Results are given 
as fold enrichment relative to IgG (n = 3). (C) Under-
phosphorylated  p107  represses  PGC1  promoter 
activity  in  growth  and  differentiation.  C2C12  cells 
were transfected with a luciferase reporter driven by 
the 3.1-kb region upstream of the ATG start site of the 
PGC-1 gene with empty vector (CTL), or with p107
HA 
and p107A4
HA in growth. Cells were also transfected 
with the luciferase reporter alone (CTL) or with p107
HA 
and differentiated for 2 d. Note that the p107 mutant 
p107A4
HA that is deficient in Cdk2 phosphorylation 
is able to significantly repress the promoter activity in 
growth and full-length p107 in differentiation (asterisks 
denote significance of the mean, P < 0.00000687 and 
P < 0.0000196, respectively; n = 9). Error bars indi-
cate SD. (D) Western blot for p107 in growth (G) and 
after 1 (1d) and 3 (3d) days differentiation of C2C12 
cells. Note that p107 becomes hypophosphorylated 
as differentiation progresses.659 Muscle fiber type determination by p107 • Scimè et al.
Cdk phosphorylation, were both significantly more efficient 
at repression.
Previously, we had documented the interaction and inhibition 
of the PGC-1 promoter activity by Rb in 3T3-L1 preadipocytes 
(Scimè et al., 2005). However, binding of Rb is not apparent in 
myoblasts. In BAT, there is evidence for enhanced RB phosphory-
lation, presumably by Cdks in cold-induced neodifferentiation 
when PGC-1 levels are increased (Hansen et al., 2004). In myo-
blasts, the PGC-1 promoter appears to be modulated directly by 
p107 interacting with bound transcription factors that are respon-
sive to upstream signals unique to myogenic cells. The differences 
in control of the two tissue types are currently being investigated.
These results imply that myogenic and adipogenic control 
mechanisms for PGC-1 expression are similar, in that they in-
volve the Rb family. Indeed, recent data suggest that brown adipo-
cytes and skeletal muscle are closely related (Seale et al., 2008). 
Lineage tracing experiments found that Myf5, a factor once thought 
to arise only in the myogenic lineage, is also present in precursors 
of brown adipocytes. Moreover, PRD1-BF1-RIZ (PRDM16)   
controls a bidirectional cell fate switch between myoblasts and 
brown adipocytes.
The classical role for the Rb family is control of the cell 
cycle by direct repression of the E2F family of transcription 
mitochondrial  gene  expression  and  oxidative  metabolism 
(Puigserver et al., 1998; Wu et al., 1999; Vega et al., 2000).   
Recent studies have described elevated levels of PGC-1 dur-
ing endurance exercise training that is correlated to fiber type 
switching from glycolytic to oxidative fibers (Pilegaard et al., 
2003; Russell et al., 2003; Akimoto et al., 2005). Indeed, trans-
genic overexpression of PGC-1 promotes the enrichment of 
pro-oxidative type I and type IIa fibers in type II muscle groups 
(Puigserver et al., 1998; Wu et al., 1999; Lin et al., 2002;   
Pilegaard et al., 2003; Russell et al., 2003).
Our results suggest that p107 functions to control PGC-1 
activity by modulating its expression. p107 acts as a repres-
sor to PGC-1 transcriptional control that is verified by the 
significantly higher levels of the coactivator that are found   
in p107-null mice. Quantitative ChIP assays revealed robust 
interaction of p107 to sequences in the PGC-1 proximal pro-
moter in both proliferating myoblasts and in differentiated myo-
cytes. In addition, transient transcription assays using luciferase 
reporters found that p107 overexpression inhibits transcrip-
tion from a 3.1-kb proximal promoter of mouse PGC-1 in 
a Cdk-dependent manner. Indeed, p107 in a hypophosphory-
lated state when Cdks are inactivated 48 h after differentia-
tion, and a mutant form that was deficient in modification by 
Figure 7.  Ectopic expression of p107 influences fiber type determination. (A) Western blot for endogenous p107 and Flag-tagged p107 of electroporated 
(Elec) Flag-p107 and contralateral untreated (Ctrl) TAs at 10- and 30-d postelectroporation (DPE). (B) PCR detection of electroporated Flag-p107 (Elec) and 
contralateral untreated (Ctrl) TA muscles after 10- and 30-d DPE. P, Flag-p107; S, empty vector (sham). (C) Type IIa MyHC (red) and Laminin (green) fluores-
cence immunostaining of representative sections for nonelectroporated and contralateral electroporated TA muscle with empty vector (Sham) or with p107. 
Note the decreased levels of type IIa oxidative fibers for the p107 electroporated muscle. (D) p107 influences the fiber type character of skeletal muscle   
in vivo. Graphical representation of the percentage of muscle fibers expressing type IIa MyHC for electroporated TA muscle with empty vector (Sham) or 
with p107 from their nonelectroporated contralateral TA. Note the significantly reduced oxidative type IIa fibers for p107 expressing TAs. The asterisk 
denotes significance (P < 0.03; n = 3). Error bars indicate SD.JCB • VOLUME 190 • NUMBER 4 • 2010   660
Materials and methods
HF diet
Experimental procedures were performed on mice with the Balb/c genetic 
background, including those with a targeted deletion of p107 (LeCouter   
et al., 1998). Procedures were performed according to the guidelines of 
the University of Ottawa. Fat pads were carefully dissected and weighed 
from 10-wk- and 1-yr-old mice unless stated. Adiposity was determined by 
dividing the total adipose tissue weight by the weight of the animal. Mice 
fed an HF diet that was made up of 60% fat (Harlan) for 2 mo were 
weighed every 3 d.
qPCR
For real-time qRT-PCR (qRT-PCR), RNA was first extracted from TA muscle 
of p107
/ and wild-type mice ranging from 12 to 16 wk in age using the 
RNeasy Fibrous Tissue kit (QIAGEN), or from primary myoblasts using 
the RNeasy kit (QIAGEN). 500 ng of RNA was reverse transcribed using 
the GeneAmp kit (Applied Biosystems). 25 ng of reverse-transcribed RNA 
was used for PCR analysis. Primer sets and conditions for PGC-1, UCP-2, 
UCP-3 Glut4, Glut5, FABP3, and CPT1b have been described previously 
(Hansen et al., 2004; Lau et al., 2004). Primer sets for p107 were as 
follows: right primer, 5-CAATGCTATAATGTGCCCAA-3; and left primer, 
5-TAGGATTCCGCATACAAGAT-3. Assays were performed on a qPCR 
system (MX 4000 [Stratagene] using SYBR green PCR Master mix [Sigma- 
Aldrich]). All reactions were run at least in triplicate and the results were 
graphed by normalizing to -actin.
Histology
H&E and NADH reductase staining of tissue sections with NBT were per-
formed according to standard protocol. Fiber type enumeration was ac-
complished by counting fluorescent stained fibers from frozen cross sections 
of TA, diaphragm, and pectoralis muscles. Antibodies used were mouse 
anti–type I MyHC (BF-34), anti–type IIa MyHC (SC-21), and anti–type IIb 
MyHC (BF-F3); and rabbit anti-Laminin (Sigma-Aldrich). Secondary antibodies 
used were Alexa Fluor 488, Alexa Fluor 568, and Alexa Fluor 647 conju-
gated to specific IgG types (Invitrogen).
Microscopy
Images were obtained at room temperature using a microscope (Axioskop;   
Carl  Zeiss,  Inc.)  with  10×  NA  0.30  Plan-Neofluar  (Carl  Zeiss,  Inc.)   
or 20× NA 0.50 Plan-Neofluar (Carl Zeiss, Inc.) objectives, and a micro-
scope (Axioplan2; Carl Zeiss, Inc.) with a 20× NA 0.75 Plan-Apochromat 
(Carl Zeiss, Inc.) objective. Digital images were captured using Axiovision 
(Carl Zeiss, Inc.) and were processed with Photoshop (Adobe). ImageJ soft-
ware was used for measuring the cross-sectional area of white adipocytes 
in tissue sections (n = 3).
In vivo electroporation
For the in vivo electro transfer, 40 µg of plasmid DNA in 0.9% NaCl or 
0.9% NaCl (saline) was injected directly into one TA muscle for each mouse 
(2-mo-old BALB/c) that had been exposed by an incision through the skin. 
Immediately after injection, electric stimulation by a pulse generator (ECM 
830; BTX) of 100 V for six pulses, with a fixed duration of 20 ms and an in-
terval of 200 ms using 5-mm needle electrodes (BTX), was applied directly 
to the TA. 21 d after transfer, the electroporated and untreated contralateral 
TAs from each mouse were dissected and treated as with histology to enu-
merate the percentage of type IIa fibers. A total of three mice was used for 
each treatment.
Indirect calorimetry
Whole body oxygen consumption (VO2) and carbon dioxide production 
(VCO2) of mice was measured using an open circuit four-chamber indirect 
calorimetry system with automatic temperature and light controls (Columbus 
Instruments). All mice had ad libitum access to water, with the HF diet mice 
having ad libitum access to HF pellets and the chow diet fed mice having ad 
libitum access to a chow diet. Mice were placed in respiration chambers 
and data were recorded before and after 1 and 2 mo on an HF diet for a 
24 h period with temperature at 24°C and light between 0700–1900 h. The 
RER was determined by the ratio of the volume of carbon dioxide eliminated 
per minute to the volume of oxygen taken into the lungs during the same time 
period over a 24 h period.
Quantitative ChIP
Quantitative ChIP was performed on growing and 2-d differentiated C2C12 
myoblasts with an assay kit (Millipore) according to the manufacturer’s   
factors, but they also have a function in differentiation and 
development. In vivo studies deleting Rb before and after myo-
genic differentiation reveal that it plays a crucial role in the 
switch from proliferation to differentiation rather than the main-
tenance of the terminally differentiated state (Huh et al., 2004). 
Until now, no data had existed for the role of the Rb family 
member p107 in skeletal muscle differentiation and mainte-
nance. Our results provide for the first time a function for p107 
in skeletal muscle that acts by controlling the pro-oxidative co-
activator PGC-1.
It is not known in what setting p107 controls slow type   
fiber formation, but many possibilities can be hypothesized. 
During muscle regeneration, the quiescent satellite cell, the 
primary adult myogenic stem cell, is activated and undergoes 
several proliferative cycles as myoblasts before fusing to form 
myotubes, which are the building blocks of myofibers (Scimè 
and Rudnicki, 2006). A subset of the myogenic precursors 
that are not committed to the myogenic program divide sym-
metrically to replenish the satellite stem cell pool (Le Grand 
et al., 2009).
The level where p107 functions in the myogenic develop-
mental program remains to be determined. p107 might function 
during the myogenic specification of satellite cells to influence 
the fiber type choice of the resulting myoblast. Hence, inacti-
vating p107 would predetermine that satellite cells differentiate 
into oxidative myofibers, as is the case in early embryogenesis 
(Stockdale, 1997). However, in skeletal muscle, p107 might   
affect fiber type determination at the level of myoblast com-
mitment to fiber fate. Thus, differentiation of myoblasts with 
higher levels of p107 might promote less oxidative fiber type 
cells and conversely lower levels of more oxidative fibers.   
Indeed, myoblasts are not homogenous; e.g., myogenic progeni-
tors within a muscle are specified to reflect the phenotype of 
the fiber type of origin (Wehrle et al., 1994; Rosenblatt et al., 
1996; Kalhovde et al., 2005; Huang et al., 2006). p107 has 
been shown to bind with E2F4 at specific myogenic promot-
ers that might potentially influence the outcome of myogen-
esis (Parakati and DiMario, 2005). Finally, p107 might control   
fiber type switching at the level of the differentiated fiber as a 
member of a sensing pathway that modulates signal transduc-
tion and gene transcription in the presence of metabolites, or 
by specific neuronal impulses (Cameron-Smith et al., 2003). 
This is consistent with the occupation and control of the PGC-1  
promoter with p107. p107 might be involved in one of the   
multiple  signaling  pathways  that  are  reprogrammed  during 
muscle fiber type determination and/or switching. Increasing 
p107 in this circumstance might cause the dysregulation of a 
variety of metabolic genes, including decreasing expression levels   
of PGC-1, contributing to the enhanced glycolytic nature of 
muscle fibers.
Understanding the underlying mechanisms of skeletal mus-
cle fiber type determination can lead to effective prevention and 
treatment strategies for the escalating obesity crisis in society.   
Indeed, the identification of a central role for p107 in determining 
muscle fiber character raises the possibility that this pathway may 
be amenable for therapeutic manipulation for the treatment 
of obesity.661 Muscle fiber type determination by p107 • Scimè et al.
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instructions. The promoter was immunoprecipitated by anti–rabbit p107 
sc-318, RB sc-50, p130 sc-317, E2F1 sc-193, E2F4 sc-1082, and con-
trol Ig antibody (all from Santa Cruz Biotechnology, Inc.). ChIP primer se-
quences amplified a 311-bp fragment corresponding to 134 to 445 bp   
within the PGC-1 upstream promoter region (right primer, 5-CCCCCGA-
TTTTCTTTCTCTC-3; and left primer, 5-GGCTTGCTTGCTTTACAAGG-3).   
The PCR conditions for quantitative ChIP were 40 cycles for 30 s at 95°C 
denaturation, 30 s at 56°C annealing, and 30 s at 72° extension.
Time course and Western blotting
For the differentiation time-course, the myoblast cell line C2C12 was differ-
entiated in differentiation media: DME containing 2% horse serum or pri-
mary myoblasts with DME containing 5% horse serum for the stated times. 
For Western blotting, cells were lysed with Ripa buffer (0.5% NP-40, 0.1% 
sodium deoxycholate, 150 mM NaCl, and 50 mM Tris-HCl, pH 7.5), then 
the lysate was loaded onto a 7.5% polyacrylamide gel and blotted accord-
ing to standard protocol with p107 c-20 (Santa Cruz Biotechnology, Inc.) 
or M2 anti-Flag (Sigma-Aldrich).
siRNA knockdown
For siRNA knockdown of p107, myoblasts were isolated from hind-limb 
muscles as previously described (Huh et al., 2004) and plated on collagen-
coated dishes in Ham’s F10 medium supplemented with 20% FBS and 5 ng/ml 
of basic FGF (Invitrogen). At 80% confluency, the cells were transfected with 
either nonsilencing or p107 siRNA (TRCN0000218550; Sigma-Aldrich) 
with Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer’s 
instructions. The myoblasts were differentiated 24 h after transfection in DME 
containing 5% horse serum for 3 d. The cells were lysed and equal amounts 
of protein were used for Western blotting with the following antibodies: anti-
skeletal myosin (M7523; Sigma-Aldrich), MyHCIIa (A4.74; Developmental 
Studies Hybridoma Bank), MyHCIIb (BF-F3; American Type Culture Collec-
tion), and p107 (sc-318; Santa Cruz Biotechnology, Inc.). Quantification of 
Western blots was performed using the ImageJ software.
Luciferase assay
For  promoter  analysis,  C2C12  cells  were  transfected  using  Superfect   
(QIAGEN)  according  to  the  manufacturer’s  instructions.  Cells  were   
harvested 24 h after transfection or re-fed after transfection with differen-
tiation media for 48 h before harvesting. The 3.1-kb proximal PGC1–
promoter–luciferase construct was provided by M. Czubryt (University of 
Manitoba, Winnipeg, Manitoba, Canada; Czubryt et al., 2003). Lucifer-
ase assays were performed using the Dual-Luciferase Reporter Assay Sys-
tem (Promega), with the pcDNA3 vector used as an empty vector control 
and for equilibrating transfection inputs. The Cdk2-deficient phosphory-
lation mutant p107A4, pcDNA-p107A4
HA, was provided by W. Harper 
(Harvard Medical School, Boston, MA; Leng et al., 2002).
Fatty acid oxidation
The measurement of fatty acid oxidation ex vivo was done essentially as 
described previously (Dyck et al., 1997). In brief, gastrocnemius skeletal 
muscle was collected from knockout and wild-type animals and cut into 
small pieces of 50 mg. The tissue was treated in a 24-well plate with   
1.5 ml of Krebs-Henseleit buffer, pH 7.4, containing 4% fatty acid–free   
bovine serum albumin (Sigma-Aldrich), 10 mM glucose, and 0.3 mM pal-
mitate (9-10-
3H, 5 mCi/ml) for 1.5 h at 37°C. Extraction was performed on 
500 µl of buffer with the addition of 2.5 ml of chloroform/methanol (2:1) 
and 1 ml of 2M KCl:2M HCl to separate the organic from the aqueous 
phase. The mixture was vortexed at 3,000 g for 5 min, and 1 ml of aqueous 
phase was re-extracted. After final extraction, a 500-µl aliquot containing 
3H2O was taken for scintillation counting, and the amount of palmitic acid 
oxidized was calculated as described previously (Dyck et al., 1997).
Online supplemental material
Fig. S1. shows that mice lacking p107 exhibit a lean metabolic pheno-
type. Graphical representations of the serum triglycerides, leptin, insulin, 
and free fatty acids from control and p107
/ mice are shown. Online 
supplemental  material  is  available  at  http://www.jcb.org/cgi/content/ 
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